Meloxicam vaginal ring - Andromaco

Drug Profile

Meloxicam vaginal ring - Andromaco

Latest Information Update: 23 Feb 2016

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Andromaco
  • Class 2 ring heterocyclic compounds; Amides; Antipyretics; Antirheumatics; Non-opioid analgesics; Nonsteroidal anti-inflammatories; Small molecules; Thiazines; Thiazoles
  • Mechanism of Action Cyclo-oxygenase 2 inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • No development reported Pregnancy

Most Recent Events

  • 23 Feb 2016 No recent reports on development identified - Phase-I/II for Pregnancy (Prevention) in Chile (Vaginal)
  • 22 Apr 2013 Andromaco completes enrolment in its phase I/II trial for Contraception in Chile (NCT01839643)
  • 01 Feb 2013 Phase-I/II clinical trials in Pregnancy (Prevention) in Chile (Vaginal)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top